compound 20 has been researched along with enalaprilat anhydrous in 1 studies
| Studies (compound 20) | Trials (compound 20) | Recent Studies (post-2010) (compound 20) | Studies (enalaprilat anhydrous) | Trials (enalaprilat anhydrous) | Recent Studies (post-2010) (enalaprilat anhydrous) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 846 | 109 | 76 |
| Protein | Taxonomy | compound 20 (IC50) | enalaprilat anhydrous (IC50) |
|---|---|---|---|
| Angiotensin-converting enzyme | Mus musculus (house mouse) | 0.0115 | |
| Angiotensin-converting enzyme | Homo sapiens (human) | 0.2405 | |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 0.0054 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0012 | |
| Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 0.0036 | |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | 0.0024 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allibone, PL; Greenlee, WJ; Patchett, AA; Perlow, DS; Ulm, EH; Vassil, TC | 1 |
1 other study(ies) available for compound 20 and enalaprilat anhydrous
| Article | Year |
|---|---|
Angiotensin-converting enzyme inhibitors: synthesis and biological activity of acyl tripeptide analogues of enalapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Dipeptides; Enalapril; Enzyme Inhibitors; Structure-Activity Relationship | 1985 |